Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
3.560
-0.320 (-8.25%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $79.23 million as of July 22, 2024.
Market Cap
79.23M
Enterprise Value
-24.69M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $79.23M, a decrease of -77.73%. That is a compound annual growth rate of -99.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 79.20M | -77.74% |
| Mar 28, 2024 | 355.83M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCYNEXIS | 80.47M |
| PMV Pharmaceuticals | 80.25M |
| Ikena Oncology | 80.11M |
| Nutriband | 79.90M |
| MAIA Biotechnology | 79.49M |
| Leap Therapeutics | 79.21M |
| Milestone Pharmaceuticals | 78.84M |
| Marinus Pharmaceuticals | 78.55M |